· Volume surge · RVMD
Revolution Medicines Inc (RVMD) jumps 11.7% as weekly turnover expands
The oncology biotech’s 12-week advance now stands at 83.7%, with Relative Strength high and volume readings supportive but not uniform.
Revolution Medicines Inc (RVMD) rose 11.7% in the week ended June 26, closing at $182.08. The 52-week weekly price path shows the move extending a strong multiweek advance rather than reflecting live intraday trading.
The gain came with active trend conditions, Relative Strength at 87.0, and Market Dynamics offering confirmation. Turnover was elevated at 24.9 million shares, equal to 1.5x the 13-week average, while the active-mover screen flagged a stronger 2.2x volume surge.